​JN.1 not expected to spread as existing Covid-19 vaccines will work: Ex-ICMR DG | India News – Times of India

 ​JN.1 not expected to spread as existing Covid-19 vaccines will work: Ex-ICMR DG | India News - Times of India

Hyderabad: New found JN.1 variable The SARS-COV-2 virus is currently not expected to spread widely in the country. Covid-19 vaccines Dr Balaram Bhargava, former director general of the Indian Council of Medical Research (ICMR), said here on Wednesday that face coverings in crowded places should be enough to deal with it.
“As far as Covid-19 is concerned we are mostly done with it except in parts of Kerala and Karnataka. We do not expect it to spread widely in the JN.1 country. It will not be a serious problem. As we see it and what the experts believe about JN.1…these vaccines will work as long as you take the preventive dose,” he said.
He also said that the government is looking into whether new Covid-19 vaccines have been developed by similar companies. Serum Institute of India (SII) using nanoparticle technology, which is being exported to the US and has been found to be effective against JN.1, can be introduced into the Indian population. SII’s recombinant spike protein nanoparticle vaccine Covovax, developed by US-based Novavax, won DGCI approval in January 2023 for use as a heterologous booster.
“Apparently, the Serum Institute has a vaccine based on nanoparticle technology, which has been exported to the US. While it is in its early days, the vaccine has shown great promise and appears to be effective against JN.1. ” said Bhargava, who was in Hyderabad to deliver the Dr MVN Shrodkar Memorial Lecture on ‘India’s Covid Vaccine Saga’. By Telangana Academy of Sciences (TAS),
He said that even the World Health Organization (WHO) has clearly stated that there is no need to conduct special (clinical) trials for each type and approve vaccines that work against different types. can be given
However, he stressed the need for vigilance and said the government was setting up many facilities for surveillance. “The only thing I can advise is to get your vaccination if not complete in terms of two doses and a booster shot. Secondly if you are going to very crowded places where there have been some cases. Then it might be wise to use a mask…” he said.
Allaying concerns about increased incidence of heart attacks in the youth due to the Covid-19 vaccine, he said none of the Covid-19 vaccines had been rushed and all were in phase-1, phase-2 and Had to go through phase-3 trials. .
“None of these vaccines, whether in the West or in India, were rushed. Yes, the recruitment (of trial subjects) was rushed, all the logistics were rushed but about stroke and acute heart attack. From reports we know that as South Asians and Indians we get heart diseases and strokes 10 years earlier. Western counterparts like us are genetically more prone to heart attacks and strokes. They also He said that the incidence of diabetes and high blood pressure is increasing in the country.

India,India News,India news today.,Today’s news,Google News,Latest news,Serum Institute of India,New version of covid,JN.1 variable,Current Covid-19 Weeks,Covid-19 vaccines

Be the first to comment

Leave a Reply

Your email address will not be published.